Literature DB >> 8182147

Inhibition by interferon-gamma of human mononuclear cell-mediated low density lipoprotein oxidation. Participation of tryptophan metabolism along the kynurenine pathway.

S Christen1, S R Thomas, B Garner, R Stocker.   

Abstract

In this study we examined the potential inhibition by interferon-gamma (IFN gamma) of the early stages of low density lipoprotein (LDL) oxidation mediated by human peripheral blood mononuclear cells (PBMC) and monocyte-derived macrophages (MDM) in Ham's F-10 medium supplemented with physiological amounts of L-tryptophan (Trp). We assessed LDL oxidation by measuring the consumption of LDL's major antioxidant (i.e., alpha-tocopherol) and targets for oxidation (cholesteryllinoleate and cholesterylarachidonate), together with the accumulation of cholesterylester hydroperoxides and the increase in relative electrophoretic mobility of the lipoprotein particle. Exposure of PBMC or MDM to IFN gamma induced the degradation of extracellular Trp with concomitant accumulation of kynurenine, anthranilic and 3-hydroxyanthranilic acid (3HAA) in the culture medium. Formation of 3HAA, but neither Trp degradation nor formation of kynurenine and anthranilic acid, was inhibited by low amounts of diphenylene iodonium (DPI) in a concentration-dependent manner. In contrast to oxidative Trp metabolism, exposure of human PBMC or MDM to IFN gamma failed to induce degradation of arginine, and nitrite was not detected in the cell supernatant, indicating that nitric oxide synthase was not induced under these conditions. Incubation of LDL in Trp-supplemented F-10 medium resulted in a time-dependent oxidation of the lipoprotein that was accelerated in the presence of PBMC or MDM but inhibited strongly in the presence of both cells and IFN gamma, i.e., when Trp degradation and formation of 3HAA were induced. In contrast, when IFN gamma was added to PBMC or MDM in F-10 medium that was virtually devoid of Trp, inhibition of cell-accelerated LDL oxidation was not observed. Exogenous 3HAA added to PBMC or purified monocytes in the absence of IFN gamma also strongly and in a concentration-dependent manner inhibited LDL oxidation. Selective inhibition of IFN gamma-induced formation of 3HAA by DPI caused reversion of the inhibitory action of this cytokine on both PBMC- and MDM-mediated LDL oxidation. These results show that IFN gamma treatment of human PBMC or MDM in vitro attenuates the extent of LDL oxidation caused by these cells, and indicate that Trp degradation with formation of 3HAA is a major contributing factor to this inhibitory activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8182147      PMCID: PMC294350          DOI: 10.1172/JCI117211

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  57 in total

1.  Oxidation of 3-hydroxyanthranilic acid to the phenoxazinone cinnabarinic acid by peroxyl radicals and by compound I of peroxidases or catalase.

Authors:  S Christen; P T Southwell-Keely; R Stocker
Journal:  Biochemistry       Date:  1992-09-01       Impact factor: 3.162

Review 2.  The role of lipid peroxidation and antioxidants in oxidative modification of LDL.

Authors:  H Esterbauer; J Gebicki; H Puhl; G Jürgens
Journal:  Free Radic Biol Med       Date:  1992-10       Impact factor: 7.376

Review 3.  Induction of haem oxygenase as a defence against oxidative stress.

Authors:  R Stocker
Journal:  Free Radic Res Commun       Date:  1990

4.  Single-step, chromogenic Limulus amebocyte lysate assay for endotoxin.

Authors:  G K Lindsay; P F Roslansky; T J Novitsky
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

5.  Rapid isolation of lipoproteins and assessment of their peroxidation by high-performance liquid chromatography postcolumn chemiluminescence.

Authors:  W Sattler; D Mohr; R Stocker
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

6.  High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors.

Authors:  V W Bowry; K K Stanley; R Stocker
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

7.  The participation of nitric oxide in cell free- and its restriction of macrophage-mediated oxidation of low-density lipoprotein.

Authors:  W Jessup; D Mohr; S P Gieseg; R T Dean; R Stocker
Journal:  Biochim Biophys Acta       Date:  1992-10-13

8.  Vitamin E in human low-density lipoprotein. When and how this antioxidant becomes a pro-oxidant.

Authors:  V W Bowry; K U Ingold; R Stocker
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

9.  Autoinhibition of murine macrophage-mediated oxidation of low-density lipoprotein by nitric oxide synthesis.

Authors:  W Jessup; R T Dean
Journal:  Atherosclerosis       Date:  1993-07       Impact factor: 5.162

10.  Interferon-gamma suppresses PDGF production from THP-1 cells and blood monocyte-derived macrophages.

Authors:  C Kosaka; J Masuda; K Shimokado; K Zen; T Yokota; T Sasaguri; J Ogata
Journal:  Atherosclerosis       Date:  1992-11       Impact factor: 5.162

View more
  13 in total

1.  Alpha-tocopheryl hydroquinone is an efficient multifunctional inhibitor of radical-initiated oxidation of low density lipoprotein lipids.

Authors:  J Neuzil; P K Witting; R Stocker
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria.

Authors:  L A Sanni; S R Thomas; B N Tattam; D E Moore; G Chaudhri; R Stocker; N H Hunt
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

3.  Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E-/- mice.

Authors:  S C Whitman; P Ravisankar; H Elam; A Daugherty
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

4.  Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice.

Authors:  X Zhou; S Stemme; G K Hansson
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

5.  Increases in Plasma Tryptophan Are Inversely Associated with Incident Cardiovascular Disease in the Prevención con Dieta Mediterránea (PREDIMED) Study.

Authors:  Edward Yu; Miguel Ruiz-Canela; Marta Guasch-Ferré; Yan Zheng; Estefania Toledo; Clary B Clish; Jordi Salas-Salvadó; Liming Liang; Dong D Wang; Dolores Corella; Montse Fitó; Enrique Gómez-Gracia; José Lapetra; Ramón Estruch; Emilio Ros; Montserrat Cofán; Fernando Arós; Dora Romaguera; Lluis Serra-Majem; Jose V Sorlí; Frank B Hu; Miguel A Martinez-Gonzalez
Journal:  J Nutr       Date:  2017-02-08       Impact factor: 4.798

Review 6.  The Footprint of Kynurenine Pathway in Cardiovascular Diseases.

Authors:  Moein Ala; Seyed Parsa Eftekhar
Journal:  Int J Tryptophan Res       Date:  2022-06-28

7.  Human blood cells support the reduction of low-density-lipoprotein-associated cholesteryl ester hydroperoxides by albumin-bound ebselen.

Authors:  J Christison; H Sies; R Stocker
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

Review 8.  Potential to inhibit growth of atherosclerotic plaque development through modulation of macrophage neopterin/7,8-dihydroneopterin synthesis.

Authors:  S P Gieseg; E M Crone; E A Flavall; Z Amit
Journal:  Br J Pharmacol       Date:  2007-08-13       Impact factor: 8.739

9.  Indoleamine 2,3-dioxygenase enzyme activity correlates with risk factors for atherosclerosis: the Cardiovascular Risk in Young Finns Study.

Authors:  M Pertovaara; A Raitala; M Juonala; T Lehtimäki; H Huhtala; S S Oja; E Jokinen; J S A Viikari; O T Raitakari; M Hurme
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330

Review 10.  Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets.

Authors:  Dipak P Ramji; Thomas S Davies
Journal:  Cytokine Growth Factor Rev       Date:  2015-05-12       Impact factor: 7.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.